Facilitated By

San Antonio Medical Foundation

SA-CCRC-Development of Therapeutics and Vaccines Against Coccidioidomycosis.

The University of Texas at San Antonio

The University of Texas at San Antonio is an emerging Tier One research institution with nearly 29,000 students.

Principal Investigator(s)
Hung, Chiung-Yu
Lopez-Ribot, Jose
Yu, Jieh-Juen
Funded by
NIH Natl Inst of Allergy/Infectious Dise
Research Start Date
Status
Active

Applied Research

Collaborative Project
Basic Research
Drug Discovery
Infectious Disease